Femto Technologies, Creator of Sensera, to Present at Aegis Capital Financial Conference
- New York – TheNewswire - May 12th, 2025 – Femto Technologies Inc. (Nasdaq: FMTO )(“ Femto ” or the “ Company ”), the pioneering AI innovator and recent CES Award winner for its cutting-edge SRS feminine wellness technology, is set to present at the upcoming Aegis Capital Financial Conference to be held on May 20-22, 2025. In the event, recognized for convening top-tier investors and industry leaders, Femto will showcase its latest advancements in harnessing artificial intelligence in the feminine wellness sector as well as biofeedback sensor-driven analytics. The Aegis Capital Financial Conference is a key forum, connecting industry experts, investors, and stakeholders interested in emerging technologies with transformative potential. It will be facilitated virtually and in person in New York City and hosted by Aegis Capital Corp., a premier full-service investment entity dedicated to delivering personalized financial wealth management and investment banking services. Operating since 1984, Aegis is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. It also provides research, sales and trading services to institutional and retail investors, while offering its investment representatives a conflict free service platform that enables a full-range of products and services including investment banking, wealth management, insurance, retirement planning, structured products, private equity, alternatives, equity research, fixed income and special purpose vehicles.
- 05/12/2025
|
FEMTO Receives Nasdaq Delisting Determination and Plans to Appeal
- May 9, 2025 – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO), a pioneering Femtech company formerly known as BYND Cannasoft Enterprises Inc., announced today that it has received on May 8, 2025 a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”), stating that based on its review of the Company's recent private placement transaction that was completed on February 26, 2025 (the “Placement”), Nasdaq has determined to delist the Company's securities pursuant to its discretionary authority under Listing Rule 5101. As set forth in its letter, Nasdaq's staff (the “Staff”) determined that the Company's issuance of large numbers of shares upon the cashless exercise and “alternative exercise” of the Warrants issued in the Placement resulted in significant dilution of existing shareholders thereby triggering the Staff's determination.
- 05/09/2025
|
U.S. Patent and Trademark Office Granted Femto Technologies Inc. a Notice of Allowance for Use of its Proprietary Smart Release System Technology
- Nasdaq-Listed Femtech Innovator, creator of Sensera, Advances AI-Driven Feminine Wellness Solution s Los Angeles, California – TheNewswire - May 7, 2025 – Femto Technologies Inc. (Nasdaq: FMTO), a pioneering Femtech company formerly known as BYND Cannasoft Enterprises Inc., announced today that the U.S. Patent and Trademark Office (USPTO) has granted it a Notice of Allowance for its proprietary Smart Release System (SRS) technology. This milestone reinforces Femto's commitment to redefining wellness solutions through AI-driven advancements.
- 05/07/2025
|
Femto Technologies Announces Reverse Split Implemented
- The reverse stock split is part of the Company's plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market April 22, 2025 – TheNewswire – Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a FemTech pioneer and the creator of Sensera, a feminine wellness product, has today announced that the previously announced 1-for-500 reverse stock split of its outstanding subordinate voting shares has been made effective today, April 22, 2025. This reverse split was approved by the board of directors of the Company on April 10, 2025.
- 04/22/2025
|
Femto Technologies Announces Reverse Split
- The reverse stock split is part of the Company's plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market
- 04/17/2025
|
Femto Technologies Inc. Announces Results of AGM
- Vancouver, BC - (April 2, 2025) – TheNewswire - Femto Technologies Inc. (Nasdaq: ( FMTO ) (“ Femto ” or the “ Company ”), a FemTech pioneer and the creator of Sensera, a feminine wellness product, is pleased to announce the results of its annual general meeting of shareholders (the “ AGM ”) held today. Shareholders approved all matters recommended by management, including: setting the number of directors at five and electing Yftah Ben Yaacov, Gabi Kabazo, Harold Wolkin, Stefania Szabo and Carmel Zigdon as directors of the Company;
- 04/02/2025
|
Femto Technologies Inc. Announces Closing of $17 Million Private Placement
- ASHKELON, ISRAEL AND VANCOUVER, BRITISH COLUMBIA – TheNewswire - FEBRUARY 28, 2025 - Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a FemTech pioneer and the creator of Sensera , a feminine wellness product, today announced the closing of its previously announced private placement of approximately $17 million of Common Shares (also known as Subordinate Voting Shares under British Columbia corporation law) and pre-funded and investor warrants at a price of $4.17 per Common Unit. The offering consisted of the sale of 4,076,736 Common Units (or Pre-Funded Units), each consisting of (i) one Common Share or Pre-Funded Warrant, (ii) one Series A Warrant to purchase one Common Share per warrant and (iii) one Series B Warrant to purchase one Common Share per warrant. The offering price per Common Unit was $4.17 (or $4.16999 for each Pre-Funded Unit, which is equal to the offering price per Common Unit sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant). The Pre-Funded Warrants are immediately exercisable and may be exercised at any time. The initial exercise price of each Series A Warrant is $5.21 per Common Share. The Series A Warrants are exercisable immediately and have a term of 60 months. The number of securities issuable under the Series A Warrants is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering. The initial exercise price of each Series B Warrant is $12.51 per Common Share or pursuant to an alternative cashless exercise option. The Series B Warrants are immediately exercisable and have a term of 30 months. The number of securities issuable under the Series B Warrants is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering.
- 02/28/2025
|
Femto Technologies Inc. Announces $17 Million Private Placement.
- ASHKELON, ISRAEL AND VANCOUVER, BRITISH COLUMBIA – FEBRUARY 26, 2025 - TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a FemTech pioneer and the creator of Sensera , a feminine wellness product, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of approximately $17 million of Common Shares (also known as Subordinate Voting Shares under British Columbia securities law) and pre-funded and investor warrants at a price of $4.17 per Common Unit. The offering consisted of the sale of Common Units (or Pre-Funded Units), each consisting of (i) one (1) Common Share or Pre-Funded Warrant, (ii) 1 Series A Warrants to purchase one (1) Common Share per warrant and (iii) 1 Series B PIPE Common Warrants to purchase one (1) Common Share per warrant. The offering price per Common Unit is $4.17 (or $4.16999 for each Pre-Funded Unit, which is equal to the offering price per Common Unit sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant). The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Unit sold in the offering, the number of Common Units in the offering will be decreased on a one-for-one basis. The initial exercise price of each Series A Common Warrant is $5.21 per Common Share. The Series A Common Warrants are exercisable immediately and expire 60 months after the initial issuance date. The number of securities issuable under the Series A Common Warrant is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering. The initial exercise price of each Series B Common Warrant is $12.51 per Common Share or pursuant to an alternative cashless exercise option. The Series B Common Warrants are exercisable immediately and expire 30 months after the initial issuance date. The number of securities issuable under the Series B Common Warrant is subject to adjustment as described in more detail in the report on Form 6-K filed in connection with the offering.
- 02/26/2025
|
Femto Technologies Inc. Announces RSU Grant
- VANCOUVER, BC – February 7, 2025 – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a Femtech pioneer and the creator of Sensera , a feminine wellness product, today announced that as part of the Company's policy to preserve the human capital employed in the Company, which is the driving force behind the constant activity and development in which the Company has been and continues to be engaged, and in order to deepen the Company's commitment to its employees, consultants and directors (and vice versa), the Company's board of directors (the “ Board ”) has approved the grant, to employees, directors and consultants of the Company, of 188,000 restricted share units (“ RSUs ”) pursuant to the Company's restricted share unit plan. The Board's approval of the grant of RSUs was also based on the recommendation of the Company's Governance, Nominating and Compensation Committee made on February 5, 2025. Each RSU entitles the holder to acquire one subordinate voting share of the Company, all of which shares will be subject to a 12-month lock-up. The RSUs vested immediately upon grant.
- 02/07/2025
|
